Saturday, January 31, 2026

Tesla, Rivian, and Lucid Surge in EV Rally—But Nikola Takes a 12% Dive

U.S. EV stocks surged, led by Tesla's 5.77% gain, while Nikola fell 12.80% amid financial struggles and speculation.

Sales and Trust: How Celltrion is Revolutionizing the European Market Directly Connected

Celltrion leverages direct sales in Europe to enhance trust and supply stability while introducing biosimilars like Omlyclo for asthma treatment.

The Puppet Dictator: Kim Jong Un REFUSES Trump Meeting Until Russia Gives Him Permission to Talk

North Korea's Choe Son-hui visits Russia amid Trump's openness to a summit, raising questions about diplomatic strategies and future talks.

Tag: GLP-1

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Novo Nordisk’s Oral Wegovy Tops 3,000 Prescriptions in Its First Week—A Challenge to Injectable GLP-1s

Novo Nordisk's Wegovy oral treatment exceeds 3,000 prescriptions in its debut week, signaling a shift towards oral obesity medications.

Novo Nordisk’s Wegovy Pill Draws 3,000 Prescriptions in Its First Week—Is Oral GLP-1 Here to Stay?

Novo Nordisk's Wegovy oral obesity treatment saw over 3,000 prescriptions in its first week, indicating strong market demand.

Patches, Implants, and Oral Films… The Drug-Delivery Format Battle After Oral Wegovy

Oral Wegovy's launch is transforming obesity treatment, focusing on user-friendly delivery methods and enhancing patient adherence.

Is RPG-102 the Future of Obesity Treatment? Discover the Breakthrough Oral Solution!

ProGen and Rani Therapeutics initiate a Phase 1 trial for RPG-102, an oral obesity treatment, aiming for effective weight loss with weekly dosing.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.